SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Kitahara Cari M)
 

Sökning: WFRF:(Kitahara Cari M) > (2020-2024) > International poole...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00012243naa a2200853 4500
001oai:DiVA.org:umu-222419
003SwePub
008240328s2024 | |||||||||||000 ||eng|
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-2224192 URI
0247 a https://doi.org/10.1200/JCO.23.011012 DOI
040 a (SwePub)umu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Timmins, Iain R.u Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom; Statistical Innovation, AstraZeneca, Cambridge, United Kingdom4 aut
2451 0a International pooled analysis of leisure-time physical activity and premenopausal breast cancer in women from 19 cohorts
264 1b American Society of Clinical Oncology,c 2024
338 a print2 rdacarrier
520 a PURPOSE: There is strong evidence that leisure-time physical activity is protective against postmenopausal breast cancer risk but the association with premenopausal breast cancer is less clear. The purpose of this study was to examine the association of physical activity with the risk of developing premenopausal breast cancer.METHODS: We pooled individual-level data on self-reported leisure-time physical activity across 19 cohort studies comprising 547,601 premenopausal women, with 10,231 incident cases of breast cancer. Multivariable Cox regression was used to estimate hazard ratios (HRs) and 95% CIs for associations of leisure-time physical activity with breast cancer incidence. HRs for high versus low levels of activity were based on a comparison of risk at the 90th versus 10th percentiles of activity. We assessed the linearity of the relationship and examined subtype-specific associations and effect modification across strata of breast cancer risk factors, including adiposity.RESULTS: Over a median 11.5 years of follow-up (IQR, 8.0-16.1 years), high versus low levels of leisure-time physical activity were associated with a 6% (HR, 0.94 [95% CI, 0.89 to 0.99]) and a 10% (HR, 0.90 [95% CI, 0.85 to 0.95]) reduction in breast cancer risk, before and after adjustment for BMI, respectively. Tests of nonlinearity suggested an approximately linear relationship (Pnonlinearity = .94). The inverse association was particularly strong for human epidermal growth factor receptor 2-enriched breast cancer (HR, 0.57 [95% CI, 0.39 to 0.84]; Phet = .07). Associations did not vary significantly across strata of breast cancer risk factors, including subgroups of adiposity.CONCLUSION: This large, pooled analysis of cohort studies adds to evidence that engagement in higher levels of leisure-time physical activity may lead to reduced premenopausal breast cancer risk.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
7001 a Jones, Michael E.u Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom4 aut
7001 a O'Brien, Katie M.u Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States4 aut
7001 a Adami, Hans-Olovu Clinical Effectiveness Group, Institute of Health and Society, University of Oslo, Oslo, Norway; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden4 aut
7001 a Aune, Dagfinnu Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom; Department of Nutrition, Oslo New University College, Oslo, Norway; Department of Research, Cancer Registry of Norway, Oslo, Norway4 aut
7001 a Baglietto, Laurau Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy4 aut
7001 a Bertrand, Kimberly A.u Slone Epidemiology Center at Boston University, MA, Boston, United States4 aut
7001 a Brantley, Kristen D.u Department of Epidemiology, Harvard T.H. Chan School of Public Health, MA, Boston, United States4 aut
7001 a Chen, Yuu Division of Epidemiology, Department of Population Health, NYU Grossman School of Medicine, New York, NY4 aut
7001 a Clague DeHart, Jessicau School of Community and Global Health, Claremont Graduate University, CA, Claremont, United States4 aut
7001 a Clendenen, Tess V.u Division of Epidemiology, Department of Population Health, NYU Grossman School of Medicine, New York, NY4 aut
7001 a Dossus, Laureu Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France4 aut
7001 a Eliassen, A Heatheru Department of Epidemiology, Harvard T.H. Chan School of Public Health, MA, Boston, United States; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, MA, Boston, United States4 aut
7001 a Fletcher, Oliviau Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom4 aut
7001 a Fournier, Agnèsu UVSQ, CESP, Gustave Roussy, Heredity, Cancer, INSERM, Paris-Saclay University, Paris-South University, Villejuif, France4 aut
7001 a Håkansson, Niclasu Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden4 aut
7001 a Hankinson, Susan E.u Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, MA, Amherst, United States4 aut
7001 a Houlston, Richard S.u Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom4 aut
7001 a Joshu, Corinne E.u Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, MD, Baltimore, Liberia4 aut
7001 a Kirsh, Victoria A.u Ontario Institute for Cancer Research, ON, Toronto, Canada; Dalla Lana School of Public Health, University of Toronto, ON, Toronto, Canada4 aut
7001 a Kitahara, Cari M.u Division of Cancer Epidemiology and Genetics, National Cancer Institute, MD, Bethesda, Liberia4 aut
7001 a Koh, Woon-Puayu Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore4 aut
7001 a Linet, Martha S.u Division of Cancer Epidemiology and Genetics, National Cancer Institute, MD, Bethesda, Liberia4 aut
7001 a Park, Hannah Luiu Department of Pathology and Laboratory Medicine, Department of Epidemiology, UC Irvine School of Medicine, CA, Irvine, United States4 aut
7001 a Lynch, Brigid M.u Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia; Physical Activity Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia4 aut
7001 a May, Anne M.u Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands4 aut
7001 a Mellemkjær, Leneu Danish Cancer Society Research Center, Copenhagen, Denmark4 aut
7001 a Milne, Roger L.u Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia4 aut
7001 a Palmer, Julie R.u Slone Epidemiology Center at Boston University, MA, Boston, United States4 aut
7001 a Ricceri, Fulviou Department of Clinical and Biological Sciences, Centre for Biostatistics, Epidemiology, Public Health, University of Turin, Turin, Italy; Unit of Epidemiology, Regional Health Service ASL TO3, Turin, Italy4 aut
7001 a Rohan, Thomas E.u Albert Einstein College of Medicine, NY, Bronx, United States4 aut
7001 a Ruddy, Kathryn J.u Department of Oncology, Mayo Clinic, MN, Rochester, United States4 aut
7001 a Sánchez, Maria-Joseu Escuela Andaluza de Salud Pública (EASP), Granada, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain4 aut
7001 a Shu, Xiao-Ouu Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, TN, Nashville, United States4 aut
7001 a Smith-Byrne, Karlu Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom4 aut
7001 a Steindorf, Karenu Division of Physical Activity, Prevention and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany4 aut
7001 a Sund, Malinu Umeå universitet,Kirurgi,Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland4 aut0 (Swepub:umu)masu0021
7001 a Vachon, Celine M.u Department of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, MN, Rochester, United States4 aut
7001 a Vatten, Lars J.u Department of Public Health and Nursing, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway4 aut
7001 a Visvanathan, Kalau Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, MD, Baltimore, Liberia4 aut
7001 a Weiderpass, Elisabeteu International Agency for Research on Cancer, World Health Organization, Lyon, France4 aut
7001 a Willett, Walter C.u Department of Epidemiology, Harvard T.H. Chan School of Public Health, MA, Boston, United States; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, MA, Boston, United States4 aut
7001 a Wolk, Alicjau Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden4 aut
7001 a Yuan, Jian-Minu Division of Cancer Control and Population Sciences, University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, PA, Pittsburgh, United States; Department of Epidemiology, School of Public Health, University of Pittsburgh, PA, Pittsburgh, United States4 aut
7001 a Zheng, Weiu Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, TN, Nashville, United States4 aut
7001 a Nichols, Hazel B.u Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, United States4 aut
7001 a Sandler, Dale P.u Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States4 aut
7001 a Swerdlow, Anthony J.u Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom; Division of Breast Cancer Research, Institute of Cancer Research, London, United Kingdom4 aut
7001 a Schoemaker, Minouk J.u Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom; Real World Solutions, Amsterdam, Netherlands4 aut
7102 a Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom; Statistical Innovation, AstraZeneca, Cambridge, United Kingdomb Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom4 org
7730 t Journal of Clinical Oncologyd : American Society of Clinical Oncologyg 42:8, s. 927-939q 42:8<927-939x 0732-183Xx 1527-7755
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-222419
8564 8u https://doi.org/10.1200/JCO.23.01101

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy